Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Pot

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Revue Medicale Suisse|April 26, 2024
[Discontinuing disease-modifying therapies in multiple sclerosis]Raphaël Bernard-Valnet, Patrice H Lalive, Gautier Bréville, et al.
Journal of Neuroinflammation|July 26, 2017
Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patientsPatrice H Lalive, Mario Kreutzfeldt, Odile Devergne, et al.
Cell Reports|January 5, 2017
EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple SclerosisAurélie S Clottu, Amandine Mathias, Andreas W Sailer, et al.
Frontiers in Neuroscience|April 24, 2026
Sex differences in the development, treatment, and prognosis of multiple sclerosis in SwitzerlandTimea-Chiara Annovazzi, Jens Kuhle, Pascal Benkert, et al.
Multiple Sclerosis and Related Disorders|July 5, 2025
Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide surveyLukas Steinegger, Veronika Kana, Caroline Pot, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 3, 2019
Human Leukocyte Antigen Genotype as a Marker of Multiple Sclerosis PrognosisAndreas P Lysandropoulos, Gaetano Perrotta, Thibo Billiet, et al.
Diabetes|January 1, 2013
Nogo-A downregulation improves insulin secretion in miceClaire B Bonal, Delphine E Baronnier, Caroline Pot, et al.
Journal of Neuroinflammation|February 8, 2022
Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitisSolenne Vigne, Donovan Duc, Benjamin Peter, et al.
Brain Cell Biology|October 25, 2007
Synaptic destabilization by neuronal Nogo-AElisabeth M Aloy, Oliver Weinmann, Caroline Pot, et al.
British Journal of Pharmacology|November 4, 2020
The oxysterol receptor GPR183 in inflammatory bowel diseasesBenjamin Misselwitz, Annika Wyss, Tina Raselli, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Revue Medicale Suisse|April 26, 2024
[Discontinuing disease-modifying therapies in multiple sclerosis]Raphaël Bernard-Valnet, Patrice H Lalive, Gautier Bréville, et al.
Journal of Neuroinflammation|July 26, 2017
Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patientsPatrice H Lalive, Mario Kreutzfeldt, Odile Devergne, et al.
Cell Reports|January 5, 2017
EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple SclerosisAurélie S Clottu, Amandine Mathias, Andreas W Sailer, et al.
Frontiers in Neuroscience|April 24, 2026
Sex differences in the development, treatment, and prognosis of multiple sclerosis in SwitzerlandTimea-Chiara Annovazzi, Jens Kuhle, Pascal Benkert, et al.
Multiple Sclerosis and Related Disorders|July 5, 2025
Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide surveyLukas Steinegger, Veronika Kana, Caroline Pot, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 3, 2019
Human Leukocyte Antigen Genotype as a Marker of Multiple Sclerosis PrognosisAndreas P Lysandropoulos, Gaetano Perrotta, Thibo Billiet, et al.
Diabetes|January 1, 2013
Nogo-A downregulation improves insulin secretion in miceClaire B Bonal, Delphine E Baronnier, Caroline Pot, et al.
Journal of Neuroinflammation|February 8, 2022
Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitisSolenne Vigne, Donovan Duc, Benjamin Peter, et al.
Brain Cell Biology|October 25, 2007
Synaptic destabilization by neuronal Nogo-AElisabeth M Aloy, Oliver Weinmann, Caroline Pot, et al.
British Journal of Pharmacology|November 4, 2020
The oxysterol receptor GPR183 in inflammatory bowel diseasesBenjamin Misselwitz, Annika Wyss, Tina Raselli, et al.
Pageof 11